Published in Biomark Res on January 20, 2017
Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09
The epigenomics of cancer. Cell (2007) 30.91
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell (1992) 27.80
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med (2003) 18.04
Epigenetics in cancer. N Engl J Med (2008) 17.36
Mutation in TET2 in myeloid cancers. N Engl J Med (2009) 16.07
DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07
The Polycomb group protein EZH2 directly controls DNA methylation. Nature (2005) 13.67
Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet (2009) 12.08
A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer (2011) 11.33
Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet (2006) 10.47
Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet (2007) 9.88
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86
Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature (2007) 8.33
Cancer epigenetics: from mechanism to therapy. Cell (2012) 7.74
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet (2011) 6.98
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature (2014) 6.83
DNA methylation: roles in mammalian development. Nat Rev Genet (2013) 6.65
Cancer epigenetics reaches mainstream oncology. Nat Med (2011) 5.83
The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer (2012) 4.97
Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet (2011) 4.85
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia (2011) 4.28
Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science (2006) 3.87
Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77
Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature (2010) 3.55
Epigenetic reprogramming in cancer. Science (2013) 3.47
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood (2001) 3.07
The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J Biol Chem (2010) 3.03
Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev (2007) 2.34
Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell (2014) 2.28
Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat Genet (2013) 2.16
The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell (2014) 1.98
Structure and function of eukaryotic DNA methyltransferases. Curr Top Dev Biol (2004) 1.91
DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res (2011) 1.85
Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer. J Biol Chem (2005) 1.79
Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer (2003) 1.75
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood (2015) 1.75
Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature (2015) 1.74
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood (2013) 1.65
Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem (2004) 1.64
Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development. Cancer Cell (2016) 1.57
DNA methylation in mammals. Cold Spring Harb Perspect Biol (2014) 1.57
Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut (2010) 1.44
DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis (2006) 1.42
Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood (2015) 1.39
A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood (2013) 1.38
DNMT3A in haematological malignancies. Nat Rev Cancer (2015) 1.36
Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol Cell Biol (2006) 1.35
DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clin Cancer Res (2009) 1.33
DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol (2015) 1.29
Linking DNA methyltransferases to epigenetic marks and nucleosome structure genome-wide in human tumor cells. Cell Rep (2012) 1.27
Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. Nature (2014) 1.27
Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci U S A (2011) 1.26
An essential role for DNA methyltransferase 3a in melanoma tumorigenesis. Biochem Biophys Res Commun (2009) 1.15
Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours. Eur J Cancer (2006) 1.12
Genetic alterations of DNA methylation machinery in human diseases. Epigenomics (2015) 1.12
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet (2016) 1.07
Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett (2003) 1.04
Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell. J Biomed Biotechnol (2010) 1.03
DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis. Nat Commun (2015) 1.02
DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression/DNA methylation in hematopoietic cells. Proc Natl Acad Sci U S A (2014) 1.02
Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas. Mol Cell Biol (2013) 1.00
Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis. Blood (2013) 0.97
Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol (2016) 0.93
Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis. Leukemia (2015) 0.91
Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma. Dis Esophagus (2011) 0.85
DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias. Cancer Cell (2016) 0.85
DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia. Cancer Discov (2016) 0.84
DNA methylation in normal and malignant hematopoiesis. Int J Hematol (2016) 0.81
The DNA methyltransferase DNMT3C protects male germ cells from transposon activity. Science (2016) 0.81
Emerging concepts of epigenetic dysregulation in hematological malignancies. Nat Immunol (2016) 0.79
DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat Commun (2016) 0.77
DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1. J Hematol Oncol (2016) 0.77
Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma. PLoS Genet (2016) 0.76
Loss of Dnmt3b accelerates MLL-AF9 leukemia progression. Leukemia (2016) 0.76